Around 8% of the world’s population suffers from a rare disease. In Belgium some 800,000 patients are affected. One of them is eighteen-month-old Oliver, who was born blind. He is closely monitored by professor Bart Leroy, whose team has made remarkable progress in the research into rare eye diseases. Still, there are quite a few stumbling blocks as well.
Ghent University alumni Rik and Bea wanted to celebrate their most recent birthday with a big party and they had a very clear gift preference: No flowers or chocolates, they wrote in the invitation, but a donation to the Marleen Temmerman Fund of Ghent University. Their fundraising initiative brought in close to €5,000 for the Fund.
In 2023, one in five Belgians was prescribed sleep medication, making Belgium the European leader. “Many people see a sleeping pill as an innocent thing,” says GP and clinical pharmacologist Ellen Van Leeuwen, “but sleeping pills are not sweets.”
They number 15,000, the colony of zebrafish in the Core Zebrafish Facility Ghent at the site of UZ Gent. They are nurtured and cared for under optimum conditions as laboratory animals by the researchers of the Centre for Medical Genetics. “But research into genetic disorders is not all we do here,” professor Paul Coucke emphasises.
Good news for sports fanatics, the summer of sports is not over yet! Our Belgian athletes will soon be competing at the Paralympic Games. Alumna Inge Bru, specialist in physical medicine and rehabilitation at Ghent University Hospital, accompanies them in Paris.
Creating new pieces of bone, muscle, skin or fat with a 3D printer to heal injuries. Sounds futuristic? The first steps are already being taken today! We spoke with plastic surgeon and professor Phillip Blondeel about his research into tissue engineering.
Sunshine and holidays equal a tanned skin for many. But we need to adjust our ideas about tanning, according to dermatologists Lieve Brochez and Isabelle Hoorens. Our behavior towards the sun and UV will cause more and more cases of skin cancer in the coming years.
The doping controls at the upcoming Olympic and Paralympic Games will again have a Ghent connection. The doping control lab of Ghent University, DoCoLab for short, is sending a team of researchers to Paris to help check many thousands of samples. Peter Van Eenoo, head of the lab, professor and cycling fan, will be part of that team: "We won't have lots of free time, but I do hope to catch some of the cycling (laughs)."
Marianne De Backer is a heavyweight in the world of biotechnology. Today she is CEO of Vir Biotechnology, a biotech company headquartered in Silicon Valley. She is a champion of women in leadership positions in this still male-dominated industry.
A recent study into Parkinson’s disease has shown that a stool transplant may constitute a new and valuable treatment of the disease. “It offers a potentially safe, effective and cost-efficient way of alleviating the symptoms and improving the quality of life of millions. A 'bacterial pill' might replace the stool transplant in the future. But more research is needed.”
HIV, the virus that causes AIDS, surfaced in the eighties. Long gone are the times when the virus was a sure death sentence. Still, even after all these years the stubborn stigma that surrounds HIV persists. Why is that and what can be done about it?
Researchers around the world are looking for innovative ways to detect and treat breast cancer. So are experimental oncologist An Hendrix and medical oncologist Hannelore Denys, two top researchers from Ghent.
